Warning
This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.

Template:DangerousInteractions/MAOI: Difference between revisions

From PsychonautWiki Archive
Jump to navigation Jump to search
>Unity
Replaced with proper APA citation (with DOI link)
>Unity
Italicized b. caapi
 
(14 intermediate revisions by 2 users not shown)
Line 1: Line 1:
*'''[[DangerousInteraction::MAOIs]]''' - This combination may increase the amount of neurotransmitters such as {{{nt}}} to dangerous or even fatal levels. Examples include '''[[syrian rue]]''', '''[[banisteriopsis caapi]]''', '''[[2C-T-2]]''', '''[[2C-T-7]]''', '''[[αMT]]''', and some [[antidepressants]].<ref>Gillman, P. K. (2005). Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. British Journal of Anaesthesia, 95(4), 434-441. https//doi.org/10.1093/bja/aei210</ref>
*'''[[[[DangerousInteraction::MAOIs]]]]''' - This combination may increase the amount of neurotransmitters such as {{{nt}}} to dangerous or even fatal levels. Examples include [[syrian rue]], [[banisteriopsis caapi|''banisteriopsis caapi'']], and some [[antidepressants]].<ref>{{cite journal|last1=Gillman|first1=P. K.|year=2005|title=Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity|journal=British Journal of Anaesthesia|volume=95|issue=4|url=https://bjanaesthesia.org/article/S0007-0912(17)34956-5/fulltext|pages=434-441|doi=10.1093/bja/aei210|pmid=16051647|doi-access=free|issn=0007-0912|eissn=1471-6771|oclc=01537271}}</ref>

Latest revision as of 17:45, 9 November 2020

  1. Gillman, P. K. (2005). "Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity". British Journal of Anaesthesia. 95 (4): 434–441. doi:10.1093/bja/aei210Freely accessible. eISSN 1471-6771. ISSN 0007-0912. OCLC 01537271. PMID 16051647.